Biotech; Medical Device; Pharmaceutical; Manufacturing; Consumer Products; Diagnostic; Consulting; Diversified
Axon Pharma; BARD; Baxter; Bayer; Becton Dickinson; Covidien; Scientific Advantage; Terumo Corporation; W.L. Gore and Associates; Medtronic
This study engaged 12 executives from 10 leading life sciences companies. Segmentation analysis was key to examining trends and effective practices. 6 participants make up the Medical Device Only Segment (MDS), while the Medical Device + Pharma Segment (MDP) consists of 6 participants.